K. Tangalakis et al., EFFECT OF MATERNAL GLUCOCORTICOID TREATMENT ON OVINE FETAL FLUIDS AT 0.6 GESTATION, Reproduction, fertility and development, 7(6), 1996, pp. 1595-1598
This study examined the effects of maternal dexamethasone treatment on
the volume and composition of fetal fluids, and on placental morpholo
gy at 0.6 gestation (80-90 days). Nine pregnant ewes were infused with
dexamethasone (D, 0.76 mg h(-1) for 72 h) while an additional nine ew
es received saline (S, 0.38 mL h(-1) for 72 h). Allantoic fluid (ALF)
volume was significantly greater (P < 0.02) in the D group (737+/-116
mL) than in the S group (190+/-55 mL), but there was no difference in
amniotic fluid (AMF) volume. The urine flow rate was 11 times higher i
n three D fetuses. The Cr-51-EDTA infused into the bladders of four fe
tuses during the final 4-5 h of the 72 infusions was detected in both
AMF and ALE Dexamethasone treatment significantly altered the composit
ion of the fetal fluids but had no affect on fetal body weight, organ
weights and placental weight; however, there were fewer cotyledons und
er 5 g (P < 0.05). In the D group, 3% of cotyledons were of the 'bovin
e' type in morphology, whereas all cotyledons in the S group were of t
he 'ovine' type. These findings suggest that prolonged exposure to lar
ge doses of glucocorticoids during pregnancy would affect the volume a
nd composition of the fetal fluids and placental morphology, with pote
ntially detrimental effects on the fetus.